Pfizer : PFE

All Pfizer Articles

1490 Articles

Paul Ausick | Jun 23, 2014 at 4:01 PM EDT

The 4 Stocks That Sank the Market

thinkstockJune 23, 2014: Markets opened mixed on Monday with the tech-heavy Nasdaq Composite starting the day with a small gain…

Trey Thoelcke | Jun 16, 2014 at 8:35 AM EDT

Deutsche Bank Prefers These Low P/E Stocks in a Market Correction

courtesy of Ford Motor CompanyTwo factors are about ready to collide, and if history is any guide, the outcome could…

Jon C. Ogg | Jun 11, 2014 at 11:45 AM EDT

Short Sellers Get Selective in High-Yield Defensive Dividend Stocks

ThinkstockThe short interest data for the final two weeks of May have been released, and the results are somewhat surprising…

Trey Thoelcke | Jun 11, 2014 at 8:55 AM EDT

Jefferies Franchise Picks: Highest Conviction Stocks to Buy Now

Wikimedia CommonsWith a very toppy market, and more than one firm on Wall Street warning of a potential summer sell-off,…

Jon C. Ogg | May 27, 2014 at 1:35 PM EDT

Pfizer’s Real Issue: Identity Crisis Against Peers

Pfizer looks like it is out of the bid now for AstraZeneca. What looks increasingly obvious for a lackluster performance…

Jon C. Ogg | May 27, 2014 at 8:55 AM EDT

The Dangers of Chasing Hopeful Merger and Buyout Stocks

ThinkstockEvery time the economy gets good again, and every time the stock market gets high again, waves of mergers and…

Trey Thoelcke | May 22, 2014 at 8:20 AM EDT

Why You Buy Big Pharma If the Market Crashes

A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is…

Jon C. Ogg | May 21, 2014 at 7:40 AM EDT

Dividend Shock: Over Half of DJIA Blue Chips Outyield 10-Year Treasury

Several things are taking place ahead of the end of May, and the number of pundits getting more worried about…

Paul Ausick | May 19, 2014 at 4:01 PM EDT

The 4 Stocks That Propped Up the Dow

thinkstockMay 19, 2014: Markets opened lower on Monday but look to close the day on the upside, even if just…

Douglas A. McIntyre | May 19, 2014 at 3:11 PM EDT

Pfizer Rises, AT&T Sinks to Lead the Dow’s Action

ThinkstockBig news from two of the market’s biggest names is making waves across Wall Street today as stocks advance through a…

Vince Calio | May 8, 2014 at 10:53 AM EDT

The Best-Selling Products of All Time

ThinkstockCreating the most popular product of the year will make consumers and investors happy. But making an all-time bestseller can…

Paul Ausick | May 6, 2014 at 4:01 PM EDT

The 4 Stocks That Tanked the Market

thinkstockMay 6, 2014: Markets opened lower on Monday and sank slowly and surely for the rest of the day. The…

Paul Ausick | May 6, 2014 at 11:05 AM EDT

Cross-Border Premium Implications in Merck-Bayer Transaction

Merck has had its consumer products business on the market since the beginning of this year, and Tuesday it announced…

Paul Ausick | May 5, 2014 at 4:01 PM EDT

The 4 Stocks That Moved the Markets

thinkstockMay 5, 2014: Markets opened lower on Monday but gamely pushed to the upside in midafternoon. General concern over the…

Paul Ausick | May 5, 2014 at 8:00 AM EDT

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

Drug giant Pfizer reported better-than-expected first-quarter 2014 earnings before markets opened Monday morning, but revenues fell short. Shares traded lower…

1 … 65 66 67 68 69 … 100

Pfizer : PFE

All Pfizer Articles

The 4 Stocks That Sank the Market

Deutsche Bank Prefers These Low P/E Stocks in a Market Correction

Short Sellers Get Selective in High-Yield Defensive Dividend Stocks

Jefferies Franchise Picks: Highest Conviction Stocks to Buy Now

Pfizer’s Real Issue: Identity Crisis Against Peers

The Dangers of Chasing Hopeful Merger and Buyout Stocks

Why You Buy Big Pharma If the Market Crashes

Dividend Shock: Over Half of DJIA Blue Chips Outyield 10-Year Treasury

The 4 Stocks That Propped Up the Dow

Pfizer Rises, AT&T Sinks to Lead the Dow’s Action

The Best-Selling Products of All Time

The 4 Stocks That Tanked the Market

Cross-Border Premium Implications in Merck-Bayer Transaction

The 4 Stocks That Moved the Markets

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

If CLARITY Clears the Senate by August, Where Does XRP Trade by Q4?

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

Pfizer : PFE

All Pfizer Articles

The 4 Stocks That Sank the Market

Deutsche Bank Prefers These Low P/E Stocks in a Market Correction

Short Sellers Get Selective in High-Yield Defensive Dividend Stocks

Jefferies Franchise Picks: Highest Conviction Stocks to Buy Now

Pfizer’s Real Issue: Identity Crisis Against Peers

The Dangers of Chasing Hopeful Merger and Buyout Stocks

Why You Buy Big Pharma If the Market Crashes

Dividend Shock: Over Half of DJIA Blue Chips Outyield 10-Year Treasury

The 4 Stocks That Propped Up the Dow

Pfizer Rises, AT&T Sinks to Lead the Dow’s Action

The Best-Selling Products of All Time

The 4 Stocks That Tanked the Market

Cross-Border Premium Implications in Merck-Bayer Transaction

The 4 Stocks That Moved the Markets

Pfizer Earnings Confirm Reasons for AstraZeneca Offer

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On

If CLARITY Clears the Senate by August, Where Does XRP Trade by Q4?

Featured Reads

64-Year-Old Tech Exec Holds $1.6 Million in One Stock. The Wrong Move Could Cost $400,000.

If You Have $1.1 Million Saved at 60, Here Is the Monthly Income You Can Actually Count On